Search Results

and responsive clinical interactions and shared decision-making, a core component of person-centered care. 15 Research indicates that routine SFD improves quality of care, such as patient–provider interactions, 16 and symptom management 17 ; however

interoperability and encourage the aggregation of patient data that will promote shared decision-making and increase understanding between patients, providers, and payers. Access to personal health data empowers patients to make informed decisions about their

’ve lost the ability to listen to patients, to capture the patient voice,” stated Dr. Bekelman, “There’s a serious disconnect.” To enhance providers’ ability to engage in shared decision-making interventions, it is essential that oncology practices make

highlight the need for improved physician-patient communication during the clinical encounter to inform the treatment plan. A shared decision-making process has been advocated to improve patient perceptions of the quality of the care experience and to

randomized clinical trials given the short duration of follow-up relative to the long latency to incident late effects. Simulation models offer one avenue for estimating an individual’s risk for a given late effect and can be integrated into shared decision-making

-negative NSCLC in a nontrial setting, which can improve the shared decision-making process and better inform treatment recommendations. In this study, 900 patients aged 70 years or older were given AC. Although there are no specific guidelines for the treatment

expectancy compared with other treatment options in properly selected individuals. The decision by patients to choose AS as the initial management strategy is dependent on individual preferences and plays an important role in shared decision-making. Further

, and whose RT can be limited to the breast and not include the nodes, Dr. Lyons added. She emphasized that shared decision-making is critical in situations such as this. “The patient may want to accept a higher risk of locoregional recurrence versus

predicted survival. These findings provide consistent evidence supporting the potential usefulness of taking baseline HRQoL into account in doctor–patient communication and in shared decision-making about the choice of treatment. We are the first to apply

absolute benefits patients may expect from adjuvant therapy in their situation. This can be weighed against known long-term adverse effects from receiving adjuvant chemotherapy, optimizing the shared decision-making process between patient and physician